Natural History Study for Patients With Angelman Syndrome
A Monocentric, Prospective, Longitudinal and Observational Natural History Study for Patients With Angelman Syndrome in CHR Citadelle Liège : NatHis-Angelman
Centre Hospitalier Universitaire de Liege
30 participants
Oct 10, 2021
OBSERVATIONAL
Conditions
Summary
This study is a 9-year natural history study for patients with Angelman syndrome in Belgium (a genetic neurodevelopmental disorder, affecting 500,000 individuals in the world). It includes a 3-year recruitment phase, a 5 year follow-up and a year to analyze the collected data. The investigators plan to include 30 patients with a semi-annual follow-up for 4 years. The investigators will collect relevant retrospective and prospective data using age-standardized scales and questionnaires for functional motor assessments and global developmental assessment.
Eligibility
Inclusion Criteria4
- Genetically confirmed diagnosis of AS
- years
- Male or Female
- Participant's carer is willing to give IC/sign a "record of consultation" for participation in the study
Exclusion Criteria1
- comorbidity that could potentially affect the results of the study coexists. This
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06229769